
Comorbid depression and anxiety are prevalent among individuals with substance use disorders (SUDs), complicating treatment outcomes and increasing relapse risk. Poor efficacy and safety concerns often limit pharmacological options for these psychiatric symptoms. Non-pharmacological interventions (NPIs)...

Substance use disorders (SUD) and psychoactive substance use (PSU) are very serious conditions that are associated with high relapse rates and morbidity. SUD/PSU have an additional health impact as they potentiate the development of illnesses including chronic pain, cardiovascular diseases, mental health...

The pervasive integration of digital media has transformed communication but also raised concerns about mental health. In 2020, the World Health Organization (WHO) acknowledged digital technology addiction as a global health issue [1]. Intensive use can lead to behavioral addictions such as smartphone...

Premenstrual syndrome (PMS) is a prevalent health concern characterised by a range of emotional, physical, and behavioural symptoms, with these symptoms typically abating with the onset of menstruation [1]. It is defined by the presence of at least one emotional, physical, or behavioural symptom that...